E-LIB Suche - Ergebnisse für: Roussel, Yanis

1

Response to the use of hydroxychloroquine in combination wi..:

Gautret, Philippe ; Hoang, Van Thuan ; Honoré, Stéphane...
International Journal of Antimicrobial Agents. 57 (2021) 1 - p. 106241 , 2021

Link: https://doi.org/10.1016/..

2

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2..:

Million, Matthieu ; Roussel, Yanis ; Gautret, Philippe.
International Journal of Antimicrobial Agents. 57 (2021) 1 - p. 106240 , 2021

Link: https://doi.org/10.1016/..

3

Be Careful With Big Data: Reanalysis of Patient Characteris..:

Roussel, Yanis ; Million, Matthieu ; Chabriere, Eric..
Clinical Infectious Diseases. 72 (2020) 11 - p. e928-e928 , 2020

Link: https://doi.org/10.1093/..

4

SARS-CoV-2: fear versus data:

Roussel, Yanis ; Giraud-Gatineau, Audrey ; Jimeno, Marie-Thérèse...
International Journal of Antimicrobial Agents. 55 (2020) 5 - p. 105947 , 2020

Link: https://doi.org/10.1016/..

5

Chloroquine and COVID-19: A western medical and scientific ..:

Million, Matthieu ; Roussel, Yanis ; Raoult, Didier
European Journal of Internal Medicine. 78 (2020) - p. 4-5 , 2020

Link: https://doi.org/10.1016/..

6

Early treatment of COVID-19 patients with hydroxychloroquin..:

Million, Matthieu ; Lagier, Jean-Christophe ; Gautret, Philippe...
Travel Medicine and Infectious Disease. 35 (2020) - p. 101738 , 2020

Link: https://doi.org/10.1016/..

7

Outcomes of 3,737 COVID-19 patients treated with hydroxychl..:

Lagier, Jean-Christophe, J.-C ; Million, Matthieu ; Gautret, Philippe...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tmaid.2020.101791. , 2020

Link: https://amu.hal.science/..

8

Outcomes of 3,737 COVID-19 patients treated with hydroxychl..:

Lagier, Jean-Christophe, J.-C ; Million, Matthieu ; Gautret, Philippe...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tmaid.2020.101791. , 2020

Link: https://amu.hal.science/..

9

Outcomes of 3,737 COVID-19 patients treated with hydroxychl..:

Lagier, Jean-Christophe, J.-C ; Million, Matthieu ; Gautret, Philippe...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tmaid.2020.101791. , 2020

Link: https://amu.hal.science/..

10

SARS-CoV-2: fear versus data:

Roussel, Yanis ; Giraud-Gatineau, Audrey ; Jimeno, Marie-Therese...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ijantimicag.2020.105947. , 2020

Link: https://amu.hal.science/..

11

Outcomes of 3,737 COVID-19 patients treated with hydroxychl..:

Lagier, Jean-Christophe ; Million, Matthieu ; Gautret, Philippe...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tmaid.2020.101791. , 2020

Link: https://hal-amu.archives..

12

SARS-CoV-2: fear versus data:

Roussel, Yanis ; Giraud-Gatineau, Audrey ; Jimeno, Marie-Therese...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ijantimicag.2020.105947. , 2020

Link: https://amu.hal.science/..

13

Real-time glioblastoma tumor microenvironment assessment by..:

Zirem, Yanis ; Ledoux, Léa ; Roussel, Lucas...
Cell Reports Medicine. 5 (2024) 4 - p. 101482 , 2024

Link: https://doi.org/10.1016/..

14

Case report: Continuous infusions of ceftazidime-avibactam ..:

Merad, Yanis ; Conrad, Anne ; Brosset, Sophie...
Frontiers in Medicine. 10 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

15

Exploration of DNA processing features unravels novel prope..:

Laroussi, Haifa ; Aoudache, Yanis ; Robert, Emilie...
Nucleic Acids Research. 50 (2022) 14 - p. 8127-8142 , 2022

Link: https://doi.org/10.1093/..